Clinical Trial

Sustained Acoustic Medicine for Osteoarthritis Pain

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated February 27, 2025 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The purpose of this study is to compare Sustained Acoustic Medicine treatment to topical pain relief gel for the symptomatic management of osteoarthritis. The study will measure pain and function scores for patients undergoing treatment.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2022-02-14; most recent amendment 2025-02-24.
Status change: Completed → Recruiting 2025-02-24
Status change: Recruiting → Completed 2023-06-23
Trial Details
NCT Number NCT05254574
Lead Sponsor ZetrOZ, Inc.
Conditions Osteoarthritis
Enrollment 200 participants
Start Date 2022-02-14
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-05-31 (estimated)
Updated on ClinicalTrials.gov 2025-02-27